Department of Health Policy and Management.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Med Care. 2019 May;57 Suppl 5 Suppl 1:S92-S99. doi: 10.1097/MLR.0000000000001103.
Patient-reported outcome (PRO) measures used during cancer care delivery improve communication about symptoms between patients and clinicians and reduce service utilization for uncontrolled symptoms. However, uptake of PROs in routine cancer care has been slow. In this paper, we describe stakeholder engagement activities used to overcome barriers to implementing PROs. Implementation occurred in 2 study settings: PROs completed in the waiting room and reviewed during clinical visits to guide symptom management for multiple myeloma (visit-based PROs); and weekly PROs completed by cancer patients between chemotherapy visits to monitor symptoms at home (remote PROs).
PRO implementation steps across studies included: (1) clinician and patient input on key symptoms, PRO measures, and identifying which PRO responses are clinically concerning to better target nursing actions; (2) developing PRO-based clinical decision support (CDS) for responding to concerning PROs; (3) training clinicians and clinical research assistants to interpret PROs and use software; and (4) describing implementation impact (frequency of concerning PRO responses and nursing actions).
Clinician and patient input was critical for identifying key symptoms, PRO measures, and clinically concerning response options. For the visit-based PRO observational study, all symptom scores appeared on a clinician dashboard, and those rated ≥1 by patients (on a 0-4 or 0-10 scale) had PRO-based CDS available for access. For the 2 remote PROs trials, stakeholders recommended that the 2 "worst" response options (eg, PRO responses of "often"/"always" or "severe"/"very severe") would trigger an automated email alert to a nurse along with PRO-based CDS. In each study, PRO-based CDS was tailored based on clinician input. Across studies, the most common nursing response to concerning PROs was counseling patients on (or providing care plans for) self-management of symptoms. In the trials, the percentage of weekly remote PROs generating an alert to a nurse ranged from 13% at an academic center to 36% in community oncology practices.
Across 3 prospective studies, PROs implemented into cancer care enabled tailored care based on issues identified on PROs. Stakeholder engagement was critical for successful implementation. This paper assists in addressing important PRO implementation challenges by describing a stakeholder-driven approach.
在癌症护理过程中使用患者报告的结局(PRO)测量方法可以改善患者与临床医生之间关于症状的沟通,并减少对未控制症状的服务利用。然而,PRO 在常规癌症护理中的应用一直缓慢。在本文中,我们描述了用于克服实施 PRO 障碍的利益相关者参与活动。实施发生在两个研究环境中:在临床就诊时在候诊室中完成并审查以指导多发性骨髓瘤的症状管理(基于就诊的 PRO);以及癌症患者在化疗就诊之间每周完成的 PRO 以监测家庭中的症状(远程 PRO)。
研究中 PRO 的实施步骤包括:(1)临床医生和患者对关键症状、PRO 测量以及确定哪些 PRO 反应具有临床意义以更好地确定护理措施提供输入;(2)为应对令人关注的 PRO 开发基于 PRO 的临床决策支持(CDS);(3)培训临床医生和临床研究助理解释 PRO 并使用软件;以及(4)描述实施影响(令人关注的 PRO 反应和护理措施的频率)。
临床医生和患者的投入对于确定关键症状、PRO 测量和具有临床意义的反应选项至关重要。对于基于就诊的 PRO 观察性研究,所有症状评分都显示在临床医生的仪表板上,并且那些被患者评为≥1 分(0-4 分或 0-10 分)的患者可获得基于 PRO 的 CDS。对于两项远程 PRO 试验,利益相关者建议,两个“最糟糕”的反应选项(例如,PRO 反应为“经常”/“总是”或“严重”/“非常严重”)将触发自动电子邮件警报发送给护士以及基于 PRO 的 CDS。在每个研究中,都根据临床医生的输入对基于 PRO 的 CDS 进行了定制。在所有研究中,对令人关注的 PRO 的最常见护理反应是为患者提供症状自我管理的咨询(或提供护理计划)。在试验中,每周向护士发出警报的远程 PRO 的百分比范围从学术中心的 13%到社区肿瘤学实践中的 36%。
在三项前瞻性研究中,将 PRO 纳入癌症护理中可根据 PRO 上确定的问题提供定制的护理。利益相关者的参与对于成功实施至关重要。本文通过描述一种利益相关者驱动的方法,有助于解决重要的 PRO 实施挑战。